Syndax Pharmaceuticals Inc. (SNDX) has disclosed a new risk, in the Regulation category.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syndax Pharmaceuticals Inc. faces significant business risks and uncertainties as outlined in their 2024 Form 10-K and Q1 2025 Form 10-Q reports filed with the SEC. These documents highlight potential factors that could materially and adversely impact the company’s business, prospects, financial condition, and operational results. Despite no material changes in risk factors since these filings, new risks may emerge, and unknown or currently deemed immaterial risks could also affect the company adversely. Stakeholders should consider these disclosures carefully when evaluating Syndax Pharmaceuticals’ future outlook.
The average SNDX stock price target is $35.10, implying 179.24% upside potential.
To learn more about Syndax Pharmaceuticals Inc.’s risk factors, click here.